Literature DB >> 11050177

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

A P Fontenot1, M Torres, W H Marshall, L S Newman, B L Kotzin.   

Abstract

Chronic beryllium disease results from beryllium exposure in the workplace and is characterized by CD4(+) T cell-mediated inflammation in the lung. Susceptibility to this disease is associated with particular HLA-DP alleles. We isolated beryllium-specific T cell lines from the lungs of affected patients. These CD4(+) T cell lines specifically responded to beryllium in culture in the presence of antigen-presenting cells that expressed class II MHC molecules HLA-DR, -DQ, and -DP. The response to beryllium was nearly completely and selectively blocked by mAb to HLA-DP. Additional studies showed that only certain HLA-DP alleles allowed presentation of beryllium. Overall, the DP alleles that presented beryllium to disease-specific T cell lines match those implicated in disease susceptibility, providing a mechanism for this association. Based on amino acid residues shared by these restricting and susceptibility DP alleles, our results provide insight into the residues of the DP beta-chain required for beryllium presentation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050177      PMCID: PMC18830          DOI: 10.1073/pnas.220430797

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4).

Authors:  E Celis; J Larson; L Otvos; W H Wunner
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

2.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

3.  Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells.

Authors:  S A Hammond; E Obah; P Stanhope; C R Monell; M Strand; F M Robbins; W B Bias; R W Karr; S Koenig; R F Siliciano
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

4.  HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

Authors:  L Richeldi; R Sorrentino; C Saltini
Journal:  Science       Date:  1993-10-08       Impact factor: 47.728

5.  HLA-DP antigen and Takayasu arteritis.

Authors:  R P Dong; A Kimura; F Numano; M Yajima; Y Hashimoto; Y Kishi; Y Nishimura; T Sasazuki
Journal:  Tissue Antigens       Date:  1992-03

6.  Epidemiology of beryllium sensitization and disease in nuclear workers.

Authors:  K Kreiss; M M Mroz; B Zhen; J W Martyny; L S Newman
Journal:  Am Rev Respir Dis       Date:  1993-10

7.  Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone.

Authors:  I Kurane; L C Dai; P G Livingston; E Reed; F A Ennis
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.

Authors:  K Kreiss; S Wasserman; M M Mroz; L S Newman
Journal:  J Occup Med       Date:  1993-03

9.  Compartmentalized immune response reflects clinical severity of beryllium disease.

Authors:  L S Newman; C Bobka; B Schumacher; E Daniloff; B Zhen; M M Mroz; T E King
Journal:  Am J Respir Crit Care Med       Date:  1994-07       Impact factor: 21.405

10.  HLA-A and DPB1 loci confer susceptibility to Graves' disease.

Authors:  R P Dong; A Kimura; R Okubo; H Shinagawa; H Tamai; Y Nishimura; T Sasazuki
Journal:  Hum Immunol       Date:  1992-11       Impact factor: 2.850

View more
  45 in total

1.  CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells.

Authors:  Andrew P Fontenot; Laia Gharavi; Sean R Bennett; Scott J Canavera; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

2.  Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.

Authors:  Andrew P Fontenot; Brent E Palmer; Andrew K Sullivan; Fenneke G Joslin; Cara C Wilson; Lisa A Maier; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

3.  Crystal structure of HLA-DP2 and implications for chronic beryllium disease.

Authors:  Shaodong Dai; Guinevere A Murphy; Frances Crawford; Douglas G Mack; Michael T Falta; Philippa Marrack; John W Kappler; Andrew P Fontenot
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-31       Impact factor: 11.205

Review 4.  Linking genetic susceptibility and T cell activation in beryllium-induced disease.

Authors:  Michael T Falta; Natalie A Bowerman; Shaodong Dai; John W Kappler; Andrew P Fontenot
Journal:  Proc Am Thorac Soc       Date:  2010-05

5.  Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.

Authors:  Lori J Silveira; Erin C McCanlies; Tasha E Fingerlin; Michael V Van Dyke; Margaret M Mroz; Matthew Strand; Andrew P Fontenot; Natalie Bowerman; Dana M Dabelea; Christine R Schuler; Ainsley Weston; Lisa A Maier
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

6.  Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.

Authors:  Karoline I Gaede; Massimo Amicosante; Manfred Schürmann; Elisabeth Fireman; Cesare Saltini; Joachim Müller-Quernheim
Journal:  J Mol Med (Berl)       Date:  2005-03-05       Impact factor: 4.599

7.  Accelerator mass spectrometry detection of beryllium ions in the antigen processing and presentation pathway.

Authors:  Brian C Tooker; Stephen M Brindley; Marina L Chiarappa-Zucca; Kenneth W Turteltaub; Lee S Newman
Journal:  J Immunotoxicol       Date:  2014-06-16       Impact factor: 3.000

8.  Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.

Authors:  James A Snyder; Eugene Demchuk; Erin C McCanlies; Christine R Schuler; Kathleen Kreiss; Michael E Andrew; Bonnie L Frye; James S Ensey; Marcia L Stanton; Ainsley Weston
Journal:  J R Soc Interface       Date:  2008-07-06       Impact factor: 4.118

9.  The uses and adverse effects of beryllium on health.

Authors:  Ross G Cooper; Adrian P Harrison
Journal:  Indian J Occup Environ Med       Date:  2009-08

10.  4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease.

Authors:  Douglas G Mack; Allison K Lanham; Brent E Palmer; Lisa A Maier; Tania H Watts; Andrew P Fontenot
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.